Research & Analysis
The Research and Analysis (R&A) Directorate performs and catalyzes research that enables health operational readiness in crises and conflict. NIDHC is uniquely situated to integrate into and collaborate with key stakeholders within the DoW, other U.S. government agencies, international partners, and non-government academic partners to leverage expertise and skill sets needed to execute the R&A mission.
Research in support of CCMDs
The Global Health Engagement Research Initiative (GHERI) supports practical research that strengthens DoW GHE efforts. Managed by NIDHC, GHERI funds applied research that addresses CCMD requirements, closes critical capability gaps, and informs evidence-based planning and execution of GHE activities. Through collaboration with DoW, interagency, academic, and international partners, GHERI translates research into practical solutions that enhance Joint Force readiness and health security cooperation. Learn more about GHERI here.
Assessment, Monitoring and Evaluation to capture program impact and efficacy
NIDHC conducts both internal and external assessment, monitoring, and evaluation (AM&E) to drive organizational learning and understand how programs and interventions advance operational readiness across military and civilian health systems. NIDHC analyzes program outcomes and effectiveness, tracks lessons learned, and informs data-driven decision-making, in alignment with the Foundations for Evidence-Based Policymaking Act of 2018 (Public Law 115-435) and DoD Instruction 5132.14: Assessment, Monitoring, and Evaluation Policy for The Security Cooperation Enterprise.
- Red Hill Registry - University of Hawaii
- Pre- and Post-Crash Care (PPCC) Program
- International Training
High-Impact Research Partnerships
NIDHC utilizes partnerships through its Military-Civilian Health Ecosystem to leverage the Nation’s leading experts to solve tough challenges related to health operational readiness. Some of our partnerships, featured below include:
- Georgetown University, who is conducting legal, regulatory, and policy analysis to update and strengthen the ability of the National Disaster Medicine System (NDMS) to effectively manage a protracted nationwide medical surge event. Understanding the specific language, authorities, and offices of primary responsibility within the relevant laws, regulations, and policies will inform operational, tactical, and strategic alterations that will best position the Nation to effectively prepare and respond. This includes but is not limited to the ability of the NDMS to execute missions to move patients, clinicians, and medical and public health resources and provide definitive care during a large-scale nationwide medical surge event. The objective of this project was to enable understanding of the authorities and policy that will make the federal interagency successful in responding to disaster and public health emergency events.
- Massachusetts Institute of Technology (MIT) Lincoln Labs, who are developing a high-fidelity, quantitative, systems-level, discrete event simulation environment developed to evaluate NDMS robustness and the effects of strategic policy changes. The simulation combines datasets of hospital bed counts, ambulances, and casualty treatment requirements with complex logic describing patient movement and resource allocation. The simulation has been used to identify critical bottlenecks in the NDMS system and provides a data-driven framework for informing federal interagency strategic investment and real-time operational guidance.
- Publication in preparation
- NIDHC is partnering with the Defense Advanced Research Projects Agency (DARPA) and experts at the University of Nebraska Medical Center (UNMC) to implement the DARPA Establishing Qualification Processes for Agile Pharmaceutical Manufacturing (EQUIP-a-PHARMA) program. This program(EQUIP-A-Pharma) seeks to demonstrate a real-time digital regulatory approval framework for multiple finished drug products produced on a single reprogrammable hardware platform. The effort supports up to four pilot agile pharmaceutical manufacturing sites that will generate the data required to inform the creation of a future regulatory framework. UNMC (through NIDHC) is conducting independent verification and validation of pharmaceutical products.